Grantham, Mayo, Van Otterloo & Co (GMO)’s Preformed Line Products PLPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Sell
610
-28,884
-98% -$10.1M ﹤0.01% 621
2026
Q1
$7.99M Sell
29,494
-7,845
-21% -$2.01M 0.02% 262
2025
Q4
$7.72M Sell
37,339
-42,392
-53% -$9.03M 0.02% 263
2025
Q3
$15.6M Buy
79,731
+913
+1% +$160K 0.04% 198
2025
Q2
$12.6M Buy
78,818
+6,718
+9% +$957K 0.04% 215
2025
Q1
$10.1M Buy
72,100
+12,297
+21% +$1.67M 0.03% 239
2024
Q4
$7.64M Buy
59,803
+1,542
+3% +$200K 0.02% 276
2024
Q3
$7.46M Buy
58,261
+7,332
+14% +$890K 0.02% 295
2024
Q2
$6.34M Buy
50,929
+11,205
+28% +$1.43M 0.02% 299
2024
Q1
$5.11M Buy
+39,724
New +$5.08M 0.02% 308
2023
Q3
Sell
-1,639
Closed -$256K 658
2023
Q2
$256K Sell
1,639
-57
-3% -$8.29K ﹤0.01% 623
2023
Q1
$217K Sell
1,696
-800
-32% -$79.5K ﹤0.01% 651
2022
Q4
$208K Buy
+2,496
New +$206K ﹤0.01% 677
2021
Q1
Sell
-3,400
Closed -$233K 916
2020
Q4
$233K Sell
3,400
-2,800
-45% -$162K ﹤0.01% 771
2020
Q3
$302K Sell
6,200
-1,200
-16% -$63.5K ﹤0.01% 691
2020
Q2
$370K Sell
7,400
-200
-3% -$9.74K ﹤0.01% 661
2020
Q1
$379K Sell
7,600
-100
-1% -$5.29K ﹤0.01% 636
2019
Q4
$465K Hold
7,700
﹤0.01% 600
2019
Q3
$420K Buy
7,700
+2,500
+48% +$134K ﹤0.01% 645
2019
Q2
$289K Hold
5,200
﹤0.01% 656
2019
Q1
$276K Buy
+5,200
New +$293K ﹤0.01% 649

Other funds holding PLPC

Grantham, Mayo, Van Otterloo & Co (GMO)'s PLPC Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Preformed Line Products (PLPC) stake by 98% in Q2 2026, selling an estimated $10.1M and leaving 610 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #621.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in PLPC in Q1 2019 and has held it in 21 quarters since. The position peaked at $15.6M in Q3 2025. 207 funds tracked by Wall St. Rank hold PLPC as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 610 shares of Preformed Line Products worth $250K as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 28,884 Preformed Line Products shares in Q2 2026, an estimated $10.1M.
  • Preformed Line Products made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #621 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Preformed Line Products in Q1 2019 and has held it in 21 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Preformed Line Products position peaked at $15.6M in Q3 2025.
  • 207 funds tracked by Wall St. Rank held Preformed Line Products as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.